HEARTSCIENCES INC

HSCSNASDAQ

🏆 #4109 by market capEarnings Sep 10US Equity

$2.05▼ $0.02 (−0.97%)

Market closed · at close

1h—

24h▼ 1.0%

7d▼ 7.0%

14d▼ 8.9%

30d▼ 22.1%

1y▼ 39.3%

🏦Market Cap

$8M

Small Cap

📈Revenue Growth (YoY)

-0.7%

Declining

📊Gross Margin

57.9%

Healthy

💵FCF Margin

—

⚖️P/S Ratio

931.0x

Expensive

Otter Score

Fair

Trading Snapshot

Day Range: $2.03 – $2.08
52-Week Range: $1.63 – $3.93
Volume: $4.16B
Avg Volume: $4.04B
Shares Outstanding: 3.9M
Next Earnings: Sep 21, 2026

Fundamentals Snapshot

Annual Revenue: $4,319
Last Q Revenue: $1,007
P/E Ratio: —
P/S Ratio: 931.0x
EPS (TTM): $-3.93
Dividend Yield: —

Why Investors Own HSCS

✓High-growth profile — revenue up +44.0% YoY with expanding US Equity exposure.
✓Healthy economics — 74% gross margin and 16% free-cash-flow margin.
✓New products and segments could unlock additional revenue streams.

⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

Financial Trends

Revenue (TTM)

$4,319▲ +47.7% YoY

Gross Margin (TTM)

74.2%▲ +2.9% YoY

Operating Income (TTM)

$492▲ +47.7% YoY

Free Cash Flow (TTM)

$691▲ +47.7% YoY

About HEARTSCIENCES INC

HeartSciences Inc. is a medical technology company dedicated to augmenting the clinical utility of electrocardiograms (ECGs) by integrating artificial intelligence (AI). The firm develops AI-enhanced ECG (AI-ECG) solutions, including an algorithm specifically designed to detect impaired cardiac relaxation or other forms of cardiac dysfunction, whether caused by heart disease or the natural aging process. Among its offerings is the MyoVista wavECG device, a 12-lead resting ECG that provides comprehensive diagnostic information concerning cardiac function alongside conventional ECG data in a single examination. Furthermore, the company offers MyoVista Insights, a cloud-based platform capable of hosting its AI-ECG algorithms across various ECG hardware systems. Established in 2007, HeartSciences Inc. operates from its headquarters in Southlake, Texas. The company was formerly named Heart Test Laboratories, Inc. until its rebranding to HeartSciences Inc. in October 2024.

🦦